A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/785 (2006.01) A61P 39/04 (2006.01)
Patent
CA 2303447
A method for treating pathogenic toxins in a mammal, such as a human, comprising treating the mammal with a therapeutically effective amount of a polymer comprising a cationic group attached to the polymer backbone. The polymer can be a homopolymer or a copolymer. In one embodiment, the polymer is a copolymer comprising a monomer having a pendant ammonium group and a hydrophobic monomer.
L'invention concerne un procédé permettant de traiter des toxines pathogènes chez un mammifère (par exemple, être humain), qui consiste à administrer audit mammifère une quantité thérapeutiquement efficace d'un polymère sur le squelette duquel est fixé un groupe cationique. Le polymère peut être un homopolymère ou un copolymère. Selon une variante, le polymère est un copolymère renfermant un monomère doté d'un groupe ammonium latéral et un monomère hydrophobe.
Mandeville W. Harry III
Neenan Thomas X.
Geltex Pharmaceuticals Inc.
Genzyme Corporation
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
LandOfFree
Cationic polymers as toxin-binding agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cationic polymers as toxin-binding agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cationic polymers as toxin-binding agents will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1944699